Hi, my name is David Mazoff (CD). I am the Managing Editor / Webmaster for both the HCV and HBV Advocate.
I'm the one who puts together everything you read at our sites and makes sure that all of our internet portals are working.
My job is made much easier because I work with the best team imaginable—people who not only scrutinize content and prepare materials for me to work with but also have or have had HCV.
I have Hep C, and I went through treatment 3 times: it didn't work for me—I still have the virus. But, I do feel a lot better than before. Let's put it this way: had I not undergone treatment, I would not have been able to function at the level required to get all of this done.
This week's eblast is minimal but important, with a focus on the Drug Pipeline and news. Several important articles were recently posted to the blog:
Don’t forget to keep checking out our blog for more about the most recent news stories.
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to email@example.com
**To receive the eblast in your email inbox simply send an e-mail to: firstname.lastname@example.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.